Publications by authors named "Reto Rufener"

Claim this Profile
T
Targeted and non-targeted proteomics to characterize the parasite proteins of metacestodes.
Joachim Müller, Matías Preza, Marc Kaethner, Reto Rufener, Sophie Braga

Front Cell Infect Microbiol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the mechanism of action of mefloquine and derivatives against the parasite Echinococcus multilocularis.
Roman Memedovski, Matías Preza, Joachim Müller, Tobias Kämpfer, Reto Rufener

Int J Parasitol Drugs Drug Resist· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Handling method affects measures of anxiety, but not chronic stress in mice.
Janja Novak, Ivana Jaric, Marianna Rosso, Reto Rufener, Chadi Touma

Sci Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rearing environment persistently modulates mouse phenotypes from the molecular to the behavioural level.
Ivana Jaric, Bernhard Voelkl, Melanie Clerc, Marc W Schmid, Janja Novak, Reto Rufener

PLoS Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte biology conserved across species: Functional insights from cattle.
Stephanie C Talker, G Tuba Barut, Heidi E L Lischer, Reto Rufener, Lilly von Münchow

Front Immunol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing.
Tanja Karpstein, Sheena Chaudhry, Solange Bresson-Hadni, Michael Hayoz, Ghalia Boubaker, Reto Rufener

Pathogens· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innate and adaptive immune responses following PD-L1 blockade in treating chronic murine alveolar echinococcosis.
Fadi Jebbawi, Anne-Pauline Bellanger, Britta Lunström-Stadelmann, Reto Rufener, Michel Dosch

Parasite Immunol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: In vitro metabolomic footprint of the Echinococcus multilocularis metacestode.
Dominic Ritler, Reto Rufener, Jia V Li, Urs Kämpfer, Joachim Müller

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short communication: Efficacy of albendazole in Echinococcus multilocularis-infected mice depends on the functional immunity of the host.
Junhua Wang, Nelson Marreros, Reto Rufener, Andrew Hemphill, Bruno Gottstein

Exp Parasitol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis.
Britta Lundström-Stadelmann, Reto Rufener, Andrew Hemphill

Int J Parasitol Drugs Drug Resist· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro metabolomic footprint of the Echinococcus multilocularis metacestode.
Dominic Ritler, Reto Rufener, Jia V Li, Urs Kämpfer, Joachim Müller

Sci Rep· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of being parasiticidal… an update on drug development for the treatment of alveolar echinococcosis.
Britta Lundström-Stadelmann, Reto Rufener, Dominic Ritler, Raphael Zurbriggen, Andrew Hemphill

Food Waterborne Parasitol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Reto Rufener, Luca Dick, Laura D'Ascoli, Dominic Ritler, Amani Hizem

Int J Parasitol Drugs Drug Resist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of mefloquine and mefloquine derivatives against Echinococcus multilocularis.
Reto Rufener, Dominic Ritler, Jana Zielinski, Luca Dick, Emerson Teixeira da Silva

Int J Parasitol Drugs Drug Resist· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a movement-based in vitro screening assay for the identification of new anti-cestodal compounds.
Dominic Ritler, Reto Rufener, Heinz Sager, Jacques Bouvier, Andrew Hemphill

PLoS Negl Trop Dis· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening of the Open Source Malaria Box Reveals an Early Lead Compound for the Treatment of Alveolar Echinococcosis.
Britta Stadelmann, Reto Rufener, Denise Aeschbacher, Markus Spiliotis, Bruno Gottstein

PLoS Negl Trop Dis· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral treatments of Echinococcus multilocularis-infected mice with the antimalarial drug mefloquine that potentially interacts with parasite ferritin and cystatin.
Tatiana Küster, Britta Stadelmann, Reto Rufener, Corina Risch, Joachim Müller

Int J Antimicrob Agents· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of echinococcosis: albendazole and mebendazole--what else?
Andrew Hemphill, Britta Stadelmann, Reto Rufener, Markus Spiliotis, Ghalia Boubaker

Parasite· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis